- Y Diweddaraf sydd Ar Gael (Diwygiedig)
- Pwynt Penodol mewn Amser (24/09/2011)
- Gwreiddiol (a wnaed Fel)
Version Superseded: 06/04/2016
Point in time view as at 24/09/2011.
There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Plant Protection Products (Fees and Charges) Regulations 2011. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Changes and effects yet to be applied by the editorial team are only applicable when viewing the latest version or prospective version of legislation. They are therefore not accessible when viewing legislation as at a specific point in time. To view the ‘Changes to Legislation’ information for this provision return to the latest version view using the options provided in the ‘What Version’ box above.
Regulation 4(1)
1. Fees for product-related applications are in accordance with the following table, and each item is charged cumulatively.
Item | Chargeable item | Fee(£) | ||||
---|---|---|---|---|---|---|
Notes | ||||||
(1) Application for authorisation under Regulation 1107/2009 not involving evaluation of technical information or data. | ||||||
(2) The fee for an application for extension of authorised use received before 1st April 2012 is £1,495. The fee for an application for extension of authorised use received on or after 1st April 2012 is £1,700. | ||||||
(3) Application for authorisation under Regulation 1107/2009 involving no technical consideration. | ||||||
(4) Application for a parallel trade permit for personal use only. | ||||||
(5) Where the application relates to a number of different products, this charge applies to each additional product. | ||||||
(6) Application for a parallel trade permit for other than personal use. | ||||||
(7) Verification that the product to be traded is identical to a product authorised in the part of the United Kingdom to which the application relates in accordance with Regulation 1107/2009. | ||||||
(8) “Standard technical stream applications” are all applications other than items 1-5, 10, 11 and 12. | ||||||
(9) The co-ordination of applications for new products or a change to an existing product. | ||||||
(10) Chemistry covers assessment of the technical specification of the active substance, safeners and synergists in the product and the physico-chemical properties of the product. | ||||||
(11) Toxicology covers assessment of the mammalian metabolism and toxicology of the active substance, safeners and synergists in the product and determination of the types of hazard to which the product can give rise. | ||||||
(12) Operator exposure additionally covers exposure of other persons resulting from the product use. | ||||||
(13) Consumer exposure covers exposure of consumers resulting from consumption of produce from treated crops, treated produce or products derived from either, including products from animals to which any such matter has been fed. | ||||||
(14) Fate and behaviour in the environment covers the potential environmental exposure from product use, including the identity and quantity of the active substance, metabolites, degradation products and reaction products, safeners and synergists which may be available in the soil, water or air and are of toxicological or environmental significance. | ||||||
(15) Ecotoxicology covers the assessment of the potential impact on non-target species likely to be at risk from exposure to the product, including the active substance, and toxicologically or environmentally significant metabolites, degradation products and reaction products, safeners and synergists. | ||||||
(16) Efficacy covers the assessment of whether a product consistently controls the target pest and whether the product adversely affects the treated crops, following crops or treated produce. | ||||||
(17) Pre-submission meetings may be held at the request of the applicant prior to the submission of an application to the United Kingdom to act as lead zonal rapporteur. | ||||||
(18) A Zonal surcharge is applied to any new product or re-registration application for which the United Kingdom has been requested to act as the Central Zone lead Member State. This fee covers the additional co-ordination and evaluation work required to support approvals in other Member States over and above what is required in the United Kingdom. Zonal surcharge 1 is the minimum additional fee applied. Zonal Surcharge 2 is applied for any use or uses required in another Member State but not in the United Kingdom. For particularly complex protocols requiring significant specialist input it may be necessary to charge a data module fee in the relevant specialist area. | ||||||
(19) The fee is equivalent to a specialist case fee and relates to requests from applicants for the United Kingdom to comment on the study design in advance of the data being generated and an application being submitted. For particularly complex protocols requiring significant specialist input it may be necessary to charge a data module fee in the relevant specialist area. | ||||||
1 | Administrative research and development application(1) | 50 | ||||
2 | Extension of use application including administration, co-ordination and technical consideration | 1,495 or 1,700 (2) | ||||
3 | Preliminary consideration of application type listed in items 4, 5, 7,12 or 13 to determine whether the application can proceed further | 220 | ||||
4 | Administrative application(3)(4) for a new product or change to an existing product— | |||||
4a | one product | 150 | ||||
4b | each additional product(5) | 50 | ||||
5 | Parallel trade applications— | |||||
5a | co-ordination of application for a new product or change to an existing product involving parallel trade(5) | 700 | ||||
5b | parallel trade verification(7) | 200 | ||||
6 | Evaluation of a label in any application | 200 | ||||
7 | Co-ordination of standard technical stream applications (9) (9) | 1,800 | ||||
8 | Evaluation of simple reasoned cases in each of the following specialist areas— | |||||
8a | chemistry(10) | 400 | ||||
8b | toxicology(11) | 400 | ||||
8c | operator exposure(12) | 400 | ||||
8d | residues and consumer exposure(13) | 400 | ||||
8e | fate and behaviour in the environment(14) | 400 | ||||
8f | ecotoxicology(15) | 400 | ||||
8g | efficacy(16) | 400 | ||||
9 | Evaluation of data, modelling and detailed scientific cases in each of the following specialist areas— | |||||
9a | chemistry(10) | 750 | ||||
9b | toxicology(11) | 750 | ||||
9c | operator exposure(12) | 750 | ||||
9d | residues and consumer exposure(13) | 750 | ||||
9e | fate and behaviour in the environment(14) | 1,800 | ||||
9f | ecotoxicology(15) | 1,800 | ||||
9g | efficacy(16) | 1,800 | ||||
10 | Withdrawal of an application for a product specified in items 2, 4, 5, 7, 12 or 13 before any work other than preliminary consideration has been done | 100 | ||||
11 | Pre-submission meetings for lead zonal re-registration and new product applications(17) | 5,000 | ||||
12 | Zonal surcharge for lead zonal re-registration and new product applications. This fee is in addition to those described in 7 to 9 above (18) | |||||
Zonal surcharge 1 | 7,500 | |||||
Zonal surcharge 2 | 15,000 | |||||
13 | Commenting on draft study protocols(19) | 400 |
2. The fees for evaluation for approval, or renewal of approval under Regulation 1107/2009 of an active substance, safener or synergist, are in accordance with the following table.
Item | Application | Fee(£) | |||||
---|---|---|---|---|---|---|---|
Notes | |||||||
(1) The initial evaluation carried out in order to notify the applicant whether his or her application can proceed further. | |||||||
(2) Application in accordance with Article 30 of Regulation 1107/2009 for a provisional authorisation in the United Kingdom (not exceeding 3 years) for a plant protection product containing a new active substance for which a decision on approval has been delayed by more than 30 months from the date of admissibility of the original application. | |||||||
(3) A full data package comprises the complete dossier (the information referred to in paragraphs 1 and 2 of Article 8 of Regulation 1107/2009) to support one or more representative use of one product. Where a data package also contains a large number of extra study reports submitted to refine risk assessments, to characterise metabolites or to support additional uses of the product, these studies will be treated as an additional partial data package. See also note (4). | |||||||
(4) The size of a partial data package is banded as a proportion of a full data package. The proportion is estimated on the basis of the amount of time required to evaluate the data and to conduct the necessary risk assessments. Applicants will be notified of the appropriate Band prior to an evaluation taking place. Partial data packages include one or more of the following— (a) additional data over and above a ‘standard’ core dossier for example situations where there are significantly more metabolites, or very large novel studies to be evaluated; (b) additional study submissions during evaluation required to clarify the initial dossier; (c) resubmissions, for example, where the previous application for approval or inclusion in Annex 1 to Directive 91/414/EEC(1) or for approval or renewal of approval under Regulation 1107/2009 has been unsuccessful and a new application is made in an attempt to address all the concerns raised from that earlier submission; (d) data to support the extension of the approval of an active substance, safener or synergist under Regulation 1107/2009 once the initial approval period has expired or to change the conditions of approval during the approval period; (e) data to support the evaluation of an active substance under Regulation 1107/2009 once the initial period of inclusion in Annex 1 of Directive 91/414/EEC has expired. The full dossier is not required just additional data to demonstrate compliance with any new guidance, regulations or scientific advances; (f) large data packages in one or more areas of the risk assessment that have been submitted in support of product related applications (e.g. re-registration and new product applications under Regulation 1107/2009) that significantly exceed the standard fees specified in the product-related application fees table (paragraph 1, items 9a-g above). (g) Additional studies submitted to support an adverse data review. | |||||||
A joint evaluation where the United Kingdom and one or more other Member States share the evaluation of a dossier and evaluation of scientific peer reviewed open literature on the active substance and its relevant metabolites will be treated as partial data packages. | |||||||
Where an active substance, safener or synergist is neither a biocontrol agent nor a pheromone | |||||||
1 | Preliminary evaluation(1) of the admissibility of an application | 5,000 | |||||
2 | Processing an application for provisional authorisation (2) | 35,000 | |||||
3 | Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for approval | 35,000 | |||||
4 | Evaluation of a full data package(3) | 110,000 | |||||
5 | Evaluation of a partial data package(4): | ||||||
Band 1 | 7,500 | ||||||
Band 2 | 15,000 | ||||||
Band 3 | 30,000 | ||||||
Band 4 | 50,000 | ||||||
Band 5 | 70,000 | ||||||
Band 6 | 90,000 | ||||||
Band 7 | 110,000 | ||||||
Where an active substance is a biocontrol agent | |||||||
6 | Evaluation of a full data package (3) | 22,500 | |||||
7 | Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for approval | 7,500 | |||||
8 | Evaluation of a partial data package(4): | ||||||
Band 1 | 5,500 | ||||||
Band 2 | 11,250 | ||||||
Band 3 | 17,000 | ||||||
Band 4 | 22,500 | ||||||
Where an active substance is a pheromone | |||||||
9 | Evaluation of a full data package(3) | 13,000 | |||||
10 | Helping the European Food Safety Authority to evaluate the draft assessment report where the United Kingdom is the rapporteur or co-rapporteur Member State in relation to an application for an approval | 7,500 | |||||
11 | Evaluation of a partial data package:(4) | ||||||
Band 1 | 3,250 | ||||||
Band 2 | 6,500 | ||||||
Band 3 | 9,750 | ||||||
Band 4 | 13,000 | ||||||
For all evaluations | |||||||
12 | Meeting before the submission of an application in support of a new active substance, safener, synergist, biocontrol agent or pheromone | 5,000 |
3. The fees for the official recognition of a test facility or organisation are in accordance with the following table(1).
Item | Activity | Fee (£) |
---|---|---|
Notes | ||
(1) Article 29(3) of Regulation 1107/2009 requires that compliance with certain authorisation requirements is established by official or officially recognised tests and analyses. | ||
1 | Initial official recognition of the test facility | 2,000 |
2 | Renewal of an official recognition | 2,000 |
3 | Each re-inspection | 1,500 |
4. The fees for work involved in assisting an applicant in preparing or submitting an application for approval of a basic substance under Article 23 of Regulation 1107/2009 are in accordance with the following table.
Item | Application | Fee(£) | ||
---|---|---|---|---|
Notes | ||||
(1) A full data package comprises the complete dossier (the information referred to in Article 23(3) of Regulation 1107/2009) to support one or more uses of the basic substance. Where a data package also contains a large number of extra study reports submitted to refine risk assessments, to characterise metabolites or to support additional uses, these studies will be treated as an additional partial data package. See also note (2). | ||||
(2) The size of a partial data package is banded as a proportion of a full data package. The percentage is estimated on the basis of the amount of time required to evaluate the data and to conduct the necessary risk assessments. Applicants will be notified of the appropriate Band prior to an evaluation taking place. Partial data packages include one or more of the following — (a) additional data over and above a ‘standard’ core dossier, for example, situations where there are significantly more metabolites, or very large novel studies to be evaluated; (b) additional study submissions during evaluation required to clarify the initial dossier; (c) resubmissions, for example, where the previous application for approval under Regulation 1107/2009 has been unsuccessful and a new application is made in an attempt to address all the concerns raised from that earlier submission; (d) data to support a change to the conditions of approval of the basic substance; (e) joint evaluation where the United Kingdom and one or more other Member States share the evaluation of the dossier; | ||||
The evaluation of scientific peer reviewed open literature on the basic substance and its relevant metabolites is treated as a partial data package. | ||||
1 | Assistance with a full data package(1) | 110,000 | ||
2 | Assistance with a partial data package(2): | |||
Band 1 | 7,500 | |||
Band 2 | 15,000 | |||
Band 3 | 30,000 | |||
Band 4 | 50,000 | |||
Band 5 | 70,000 | |||
Band 6 | 90,000 | |||
Band 7 | 110,000 |
Regulation 4(2)
Fees for product-related applications are in accordance with the following table.
Item | Category | Fee(£) |
---|---|---|
Notes | ||
(1) This category is mainly for plant protection products not currently authorised in any Member State. In certain cases, it may also include plant protection products still being reviewed if toxicological endpoints have not yet been agreed at a European level. | ||
(2) This category is for plant protection products where toxicological endpoints have already been agreed at a European level, but the residue definition has only been established for crop groups unrelated to the intended use or imported produce. | ||
(3) This category is for plant protection products where relevant toxicological endpoints and residue definition have already been agreed at European level. | ||
1 | Full Human health description(1) | 15,600 |
2 | Metabolism and residues evaluation(2) | 6,500 |
3 | Residues evaluation(3) | 1,950 |
OJ No. L230, 19.8.1991, p.1.
Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.
Gwreiddiol (Fel y’i Deddfwyd neu y’i Gwnaed): Mae'r wreiddiol fersiwn y ddeddfwriaeth fel ag yr oedd pan gafodd ei deddfu neu eu gwneud. Ni wnaed unrhyw newidiadau i’r testun.
Pwynt Penodol mewn Amser: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Rhychwant ddaearyddol: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Dangos Llinell Amser Newidiadau: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Mae Memoranda Esboniadol yn nodi datganiad byr o ddiben Offeryn Statudol ac yn rhoi gwybodaeth am ei amcan polisi a goblygiadau polisi. Maent yn ceisio gwneud yr Offeryn Statudol yn hygyrch i ddarllenwyr nad oes ganddynt gymhwyster cyfreithiol, ac maent yn cyd-fynd ag unrhyw Offeryn Statudol neu Offeryn Statudol Drafft a gyflwynwyd ger bron y Senedd o Fehefin 2004 ymlaen.
Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:
Impact Assessments generally accompany all UK Government interventions of a regulatory nature that affect the private sector, civil society organisations and public services. They apply regardless of whether the regulation originates from a domestic or international source and can accompany primary (Acts etc) and secondary legislation (SIs). An Impact Assessment allows those with an interest in the policy area to understand:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:
liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys